share_log

Mateon Therapeutics Inc | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  May 20, 2020 09:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more